miR-204 Negatively Regulates Cell Growth And Metastasis By Targeting ROBO4 In Human Bladder Cancer

References

• Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96–108. doi:10.1016/j.eururo.2016.06.01027370177
   PubMed Web of Science ®Google Scholar
• Dy GW, Gore JL, Forouzanfar MH, Naghavi M, Fitzmaurice C. Global burden of urologic cancers, 1990–2013. Eur Urol. 2017;71(3):437–446. doi:10.1016/j.eururo.2016.10.00828029399
   PubMed Web of Science ®Google Scholar
• Poli G, Brancorsini S, Cochetti G, Barillaro F, Egidi MG, Mearini E. Expression of inflammasome-related genes in bladder cancer and their association with cytokeratin 20 messenger RNA. Urol Oncol. 2015;33(12):505.e1–7. doi:10.1016/j.urolonc.2015.07.012
   PubMed Web of Science ®Google Scholar
• Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA. Economic burden of bladder cancer across the European Union. Eur Urol. 2016;69(3):438–447. doi:10.1016/j.eururo.2015.10.02426508308
   PubMed Web of Science ®Google Scholar
• Berdik C. Unlocking bladder cancer. Nature. 2017;551(7679):S34–S35. doi:10.1038/551S34a29117159
   PubMed Web of Science ®Google Scholar
• Dobruch J, Daneshmand S, Fisch M, et al. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69(2):300–310. doi:10.1016/j.eururo.2015.08.03726346676
   PubMed Web of Science ®Google Scholar
• Poli G, Cochetti G, Boni A, Egidi MG, Brancorsini S, Mearini E. Characterization of inflammasome-related genes in urine sediments of patients receiving intravesical BCG therapy. Urol Oncol. 2017;35(12):674.e19–674.e24. doi:10.1016/j.urolonc.2017.08.004
   PubMed Web of Science ®Google Scholar
• Hausser J, Zavolan M. Identification and consequences of miRNA-target interactions–beyond repression of gene expression. Nat Rev Genet. 2014;15(9):599–612. doi:10.1038/nrg376525022902
   PubMed Web of Science ®Google Scholar
• Seok H, Ham J, Jang ES, Chi SW. MicroRNA target recognition: insights from transcriptome-wide non-canonical interactions. Mol Cells. 2016;39(5):375–381. doi:10.14348/molcells.2016.001327117456
   PubMed Web of Science ®Google Scholar
• Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610. doi:10.1038/nrg284320661255
   PubMed Web of Science ®Google Scholar
• Tutar Y. miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014;15(5):429. doi:10.2174/13892010150514082816133525189575
   PubMed Web of Science ®Google Scholar
• Romero-Cordoba SL, Salido-Guadarrama I, Rodriguez-Dorantes M, Hidalgo-Miranda A. miRNA biogenesis: biological impact in the development of cancer. Cancer Biol Ther. 2014;15(11):1444–1455. doi:10.4161/15384047.2014.95544225482951
   PubMed Web of Science ®Google Scholar
• Osaki M, Okada F, Ochiya T. miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence. Ther Deliv. 2015;6(3):323–337. doi:10.4155/tde.14.12225853308
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222. doi:10.1038/nrd.2016.24628209991
   PubMed Web of Science ®Google Scholar
• Svoronos AA, Engelman DM, Slack FJ. OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer. Cancer Res. 2016;76(13):3666–3670. doi:10.1158/0008-5472.CAN-16-035927325641
   PubMed Web of Science ®Google Scholar
• Blanca A, Cheng L, Montironi R, et al. Mirna expression in bladder cancer and their potential role in clinical practice. Curr Drug Metab. 2017;18(8):712–722. doi:10.2174/138920021866617051816450728524002
   PubMed Web of Science ®Google Scholar
• Mitash N, Tiwari S, Agnihotri S, Mandhani A. Bladder cancer: micro RNAs as biomolecules for prognostication and surveillance. Indian J Urol. 2017;33(2):127–133. doi:10.4103/0970-1591.20341228469300
   PubMed Web of Science ®Google Scholar
• Liu Z, Long J, Du R, Ge C, Guo K, Xu Y. miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer. Tumour Biol. 2016;37(6):8327–8335. doi:10.1007/s13277-015-4627-026729198
   PubMedGoogle Scholar
• Wang X, Qiu W, Zhang G, Xu S, Gao Q, Yang Z. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway. Int J Clin Exp Pathol. 2015;8(5):5017–5025.26191195
   PubMed Web of Science ®Google Scholar
• Shuai F, Wang B, Dong S. MicroRNA-204 inhibits the growth and motility of colorectal cancer cells by downregulation of CXCL8. Oncol Res. 2018;26(8):1295–1305. doi:10.3727/096504018X1517274720902029402343
   PubMed Web of Science ®Google Scholar
• Blockus H, Chédotal A. Slit-Robo signaling. Development. 2016;143(17):3037–3044. doi:10.1242/dev.13282927578174
   PubMed Web of Science ®Google Scholar
• Legg JA, Herbert JM, Clissold P, Bicknell R. Slits and roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis. 2008;11(1):13–21. doi:10.1007/s10456-008-9100-x18264786
   PubMed Web of Science ®Google Scholar
• Li Y, Cheng H, Xu W, Tian X, Li X, Zhu C. Expression of robo protein in bladder cancer tissues and its effect on the growth of cancer cells by blocking robo protein. Int J Clin Exp Pathol. 2015;8(9):9932–9940.26617702
   PubMed Web of Science ®Google Scholar
• Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99(24):15524–15529. doi:10.1073/pnas.24260679912434020
   PubMed Web of Science ®Google Scholar
• Mearini E, Poli G, Cochetti G, Boni A, Egidi MG, Brancorsini S. Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer. Onco Targets Ther. 2017;22(10):2665–2673. doi:10.2147/OTT.S132680
   Google Scholar
• Jafri MA, Al-Qahtani MH, Shay JW. Role of miRNAs in human cancer metastasis: implications for therapeutic intervention. Semin Cancer Biol. 2017;44:117–131. doi:10.1016/j.semcancer.2017.02.00428188828
   PubMed Web of Science ®Google Scholar
• Andrews WD, Barber M, Parnavelas JG. Slit-Robo interactions during cortical development. J Anat. 2007;211(2):188–198. doi:10.1111/j.1469-7580.2007.00750.x17553100
   PubMed Web of Science ®Google Scholar
• Boles KS, Schmieder AH, Koch AW, et al. MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma model. Faseb J. 2010;24(11):4262–4270. doi:10.1096/fj.10-15793320585027
   PubMed Web of Science ®Google Scholar